Kevin Buckley

Medical Device, Pharmaceutical, and Biotechnology Patent Attorney Kevin Buckley

kevin@torreypineslaw.com
+1 (858) 869-1250

Kevin is the founder of Torrey Pines Law Group, and has more than 20 years of experience with intellectual property, transactional, and regulatory matters for high technology businesses. His clients include biotechnology, pharmaceutical, specialty chemical, medical device, digital health, diagnostics, software, analytics, mobile app, and convergence technology businesses. The "convergence" often includes machine learning (deep learning, artificial intelligence) and complex algorithms.

Areas of focus include:

  • IP, transactional, and regulatory counseling
  • International patent preparation and prosecution
  • Corporate and commercial transactions
  • Technology licensing
  • Investment funding and due diligence
  • Legal opinion drafting
  • Litigation avoidance, and
  • IP infringement litigation

Prior to founding Torrey Pines Law Group, he led the Life Sciences Practice of a large national law firm. He also worked in a major American university where he handled all legal affairs for the Office of Research & Commercialization. He was also chief legal counsel to a private research foundation where he advised the Board regarding complex corporate governance matters. For many years, Kevin was recognized nationally for his law practice by The Best Lawyers in America®.

Kevin is currently an academic advisor to the University of California, Hastings College of Law "Startup Legal Garage," and was previously an academic advisor to entrepreneurship centers at the University of Pennsylvania and Washington University in St. Louis. Kevin was also an Adjunct Professor at Washington University School of Law where he taught a Biotechnology Law intersession course. Prior to becoming a patent attorney, Kevin was a biochemist in both academics and industry.

Outside his law practice, Kevin enjoys mountaineering and hiking the California backcountry. What he loves most, however, is spending time outdoors every day with his daughter, family, and friends.

Kevin received a Bachelor of Science degree in Biochemistry/Chemistry from UC San Diego where he was an undergraduate Research Scholar. He then received a Juris Doctorate from the University of Pittsburgh School of Law where he was Editor-in-Chief of the Pittsburgh Journal of Technology Law and Policy.

Distinctions

Kevin has been selected by his peers for inclusion in:

  • The Best Lawyers in America® - Biotechnology Law
  • Philadelphia's Best Lawyers
  • SuperLawyers Rising Star
  • St. Louis Magazine Best Lawyers
  • St. Louis Business Journal "Who's Who in Technology"
  • St. Louis Business Journal "40 Under Forty"

Featured Publications & Presentations

  • Tax Reform Aims to Keep IP in the U.S., San Diego Business Journal (February 1, 2019)
  • Legal, Financial and Tax Strategies for Start-Ups, Sanford Consortium for Regenerative Medicine, San Diego, CA (January 28, 2015)
  • IP Strategy Informed by the Commercialization Process, Pennsylvania Bio Inaugural Knowledge Fair, Valley Forge, PA (June 8, 2011)
  • Entrepreneurial Investing - Management 424/524, Washington University Olin Business School, St. Louis, MO (October 13, 2009 and March 2, 2010)
  • Bringing Overseas Start-Ups Into the U.S., Inaugural Global Healthcare Investing Conference, Cleveland, OH (June 20, 2007)

Jurisdictions

Kevin is registered to practice before the U.S. Patent & Trademark Office, and admitted to practice law in Missouri and Pennsylvania. He is also admitted to the Federal Circuit Court of Appeals.